Artivion Inc. (AORT)
NYSE: AORT
· Real-Time Price · USD
43.44
-0.05 (-0.11%)
At close: Sep 08, 2025, 3:59 PM
43.44
0.00%
After-hours: Sep 08, 2025, 06:20 PM EDT
Artivion Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Jun 30, 2015 | Sep 30, 2014 | Jun 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aortic Stent Grafts Revenue | 39.84M | 36.6M | 30.14M | 28.64M | 32.19M | 32.1M | 27.44M | 25.52M | 28.36M | 17.66M | 23.74M | 19.67M | 23.83M | 25.51M | 15.52M | 20.9M | 21.06M | 20.2M | 13.67M | 12.07M | 10.12M | 12.2M | 13.35M | 12.61M | 12.41M | 11.73M | 11.34M | 11.89M | 10.31M | 9.99M | 8.33M | 9.86M | 8.86M | 9.07M | 8.89M | 9.55M | 6.71M | 15.61M | 1K | 29K |
| Aortic Stent Grafts Revenue Growth | +8.85% | +21.42% | +5.24% | -11.02% | +0.27% | +17.01% | +7.50% | -10.00% | +60.62% | -25.62% | +20.66% | -17.45% | -6.56% | +64.34% | -25.73% | -0.80% | +4.25% | +47.83% | +13.27% | +19.29% | -17.10% | -8.57% | +5.83% | +1.61% | +5.79% | +3.48% | -4.63% | +15.32% | +3.16% | +20.02% | -15.57% | +11.31% | -2.35% | +2.06% | -6.95% | +42.28% | -56.98% | +1560700.00% | -96.55% | n/a |
| On X Revenue | 25.57M | 21.57M | 22.18M | 21.48M | 20.64M | 19.68M | 20.18M | 18.74M | 17.95M | 1.78M | 16.82M | 16.46M | 16.25M | 14.37M | 1.85M | 14.02M | 14.73M | 13.1M | 17.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| On X Revenue Growth | +18.53% | -2.72% | +3.26% | +4.03% | +4.90% | -2.48% | +7.67% | +4.45% | +907.07% | -89.41% | +2.22% | +1.24% | +13.11% | +677.23% | -86.81% | -4.78% | +12.46% | -24.72% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Products Revenue | 2.74M | 2.52M | 2.4M | 2.69M | 1.83M | 2.35M | 3.01M | 3.25M | 3.13M | 20.94M | 1.71M | 1.74M | 2.88M | 1.98M | 18.48M | 1.65M | 2.42M | 2.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Products Revenue Growth | +9.02% | +4.66% | -10.50% | +46.78% | -22.09% | -22.01% | -7.21% | +3.64% | -85.04% | +1125.16% | -2.01% | -39.47% | +45.21% | -89.26% | +1023.28% | -32.08% | +9.25% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Preservation Services Revenue | 25.53M | 20.18M | 19.93M | 24.54M | 24.81M | 26.32M | 24.53M | 24.11M | 23.25M | 16.7M | 20.77M | 21.59M | 21.4M | 19.67M | 20.32M | 19.1M | 20.07M | 17.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Preservation Services Revenue Growth | +26.50% | +1.23% | -18.75% | -1.10% | -5.73% | +7.30% | +1.74% | +3.69% | +39.18% | -19.58% | -3.79% | +0.87% | +8.81% | -3.22% | +6.41% | -4.84% | +13.13% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Surgical Sealants Revenue | 19.29M | 18.11M | 22.65M | 18.44M | 18.55M | 16.98M | 18.51M | 16.23M | 16.57M | 26.15M | 16.36M | 17.37M | 15.97M | 15.68M | 23.22M | 16.54M | 17.86M | 17.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Surgical Sealants Revenue Growth | +6.53% | -20.05% | +22.83% | -0.58% | +9.21% | -8.28% | +14.04% | -2.00% | -36.65% | +59.87% | -5.85% | +8.81% | +1.82% | -32.47% | +40.37% | -7.39% | +0.20% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|
| Asia Pacific Segment Revenue | 11.13M | 8.21M | 9.57M | 10.37M | 9.65M | 7.61M |
| Asia Pacific Segment Revenue Growth | +35.51% | -14.21% | -7.64% | +7.39% | +26.86% | n/a |
| Europe, The Middle East, And Africa Segments Revenue | 38.71M | 37.05M | 33.36M | 30.42M | 34.15M | 33.59M |
| Europe, The Middle East, And Africa Segments Revenue Growth | +4.50% | +11.04% | +9.66% | -10.90% | +1.66% | n/a |
| Latin America Segment Revenue | 5.56M | 5.93M | 5.11M | 5.9M | 5.56M | 5.31M |
| Latin America Segment Revenue Growth | -6.19% | +15.95% | -13.39% | +6.15% | +4.77% | n/a |
| North America Segment Revenue | 57.57M | 47.79M | 49.26M | 49.09M | 48.66M | 50.93M |
| North America Segment Revenue Growth | +20.45% | -2.98% | +0.35% | +0.88% | -4.45% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 57.66M | 54.7M | 51.43M | 50.02M | 47.52M | 48.14M | 50.28M | 51.09M | 57.24M | 45.54M | 38.45M | 41.05M | 38.98M | 38.95M | 51.25M | 39.05M | 40.83M | 38.64M | 36.1M | 33.74M | 32.29M | 39M | 37.61M | 34.26M | 34.62M | 36.52M | 42.53M | 32.87M | 34.73M | 37.35M | 30.2M | 24.76M | 23.39M | 22.87M | 29.25M | 20.59M | 22.44M | 26.27M | 19.14M | 17.49M | 19.33M | 18.97M |
| Selling, General, and Administrative Revenue Growth | +5.41% | +6.37% | +2.82% | +5.25% | -1.28% | -4.26% | -1.60% | -10.74% | +25.68% | +18.44% | -6.33% | +5.30% | +0.07% | -23.99% | +31.24% | -4.35% | +5.67% | +7.02% | +6.99% | +4.51% | -17.21% | +3.70% | +9.78% | -1.05% | -5.19% | -14.13% | +29.38% | -5.34% | -7.02% | +23.69% | +21.97% | +5.84% | +2.26% | -21.80% | +42.03% | -8.22% | -14.61% | +37.28% | +9.40% | -9.48% | +1.89% | n/a |
| Research and Development Revenue | 7.06M | 6.73M | 7.4M | 6.61M | 7.5M | 6.95M | 7.64M | 6.42M | 7.42M | 7.22M | 8.3M | 11.8M | 8.65M | 10.13M | 9.46M | 9.97M | 8.36M | 7.75M | 6.57M | 5.75M | 5.52M | 6.36M | 5.31M | 6.26M | 5.84M | 5.55M | 6.78M | 5.22M | 5.72M | 5.37M | 6.36M | 4.28M | 4.73M | 4.09M | 3.84M | 3.71M | 3.28M | 2.61M | 2.54M | 2.96M | 2.68M | 2.25M |
| Research and Development Revenue Growth | +4.98% | -9.13% | +12.10% | -11.90% | +7.93% | -9.14% | +19.06% | -13.44% | +2.70% | -13.02% | -29.62% | +36.44% | -14.61% | +7.06% | -5.13% | +19.28% | +7.82% | +17.95% | +14.23% | +4.22% | -13.12% | +19.65% | -15.13% | +7.16% | +5.28% | -18.22% | +29.84% | -8.64% | +6.50% | -15.61% | +48.77% | -9.54% | +15.51% | +6.48% | +3.50% | +13.27% | +25.68% | +2.72% | -14.19% | +10.28% | +19.18% | n/a |